找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

123456
返回列表
打印 上一主題 下一主題

Titlebook: Hormone Related Cancer Mechanistic and Nanomedicines; Challenges and Prosp Mahfoozur Rahman,Waleed H Almalki,Khalid S Alharbi Book 2022 The

[復(fù)制鏈接]
樓主: CHORD
51#
發(fā)表于 2025-3-30 10:32:47 | 只看該作者
52#
發(fā)表于 2025-3-30 15:03:28 | 只看該作者
53#
發(fā)表于 2025-3-30 17:20:50 | 只看該作者
54#
發(fā)表于 2025-3-31 00:26:29 | 只看該作者
Book 2022g the imaging and drug delivery functions in one single nanoformulation, providing vital insights into the identification of tumour and predicting the efficacy of nanomedicine. For its unique properties, which include their small size and biocompatibility and ability to permeate the cellular membran
55#
發(fā)表于 2025-3-31 01:53:20 | 只看該作者
Progress of Cancer Nano Medicine, Clinical Hurdles, and Opportunities,rteries and accumulate in plasma at high levels. In this chapter, we will look at the advancements of nanomedicine in all areas of pharmaceuticals. We will also discuss the challenges encountered during clinical testing and development of cancer medicines, as well as future opportunities.
56#
發(fā)表于 2025-3-31 06:25:12 | 只看該作者
Challenges and Opportunities in the Delivery of Oral Anticancer Therapeutics,ilability, pharmacokinetics, and biodistribution profiles. Here, we define the drug delivery challenges related to oral routes of administration and review innovative DDS, marketed or in development, that answer those challenges.
57#
發(fā)表于 2025-3-31 11:19:43 | 只看該作者
Nanocarriers-Based Targeted Therapies for Pancreatic Cancer and Challenges Ahead,sis. Recently, significant attempts have been made to provide targeted-based nanocarriers to treat pancreatic cancer. This chapter tries to give information about the new possibilities of targeting pancreatic cancer via nanocarriers and challenges ahead.
123456
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-15 14:15
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南丹县| 玉环县| 寿阳县| 大关县| 伽师县| 平塘县| 油尖旺区| 青岛市| 永顺县| 宜州市| 蓬莱市| 繁昌县| 抚远县| 台南县| 云龙县| 昌乐县| 观塘区| 大足县| 忻州市| 定州市| 巴中市| 弋阳县| 和静县| 抚远县| 济南市| 百色市| 涿州市| 宁阳县| 特克斯县| 广元市| 兰溪市| 海丰县| 乌拉特后旗| 时尚| 义乌市| 阜南县| 奈曼旗| 鄄城县| 莱西市| 延吉市| 安远县|